Provide Current Location
Sign in to see your saved address

INTAS PHARMACEUTICALS LTD.

Pregabid Cr 165Mg Tab (10 Tab)

₹ 287.60 / Piece

₹ 359.50

20%

Whatsapp
Facebook

⭐Important Notice⭐

* T & C Apply.
* Product MRP can be changed without prior notice.
* Product offer can be withdrawn, modified, and removed by the company without prior notice.
* Product images sometimes change based on stock availability.
* Delivery lead time can vary depending on traffic and availability.
* product availability as per location-wise stock matters.
* Please check the details of medicines Name, Strength, Quantity, Batch No., Expiry date, etc., with your prescription
Please understand that after accepting the medicines, we shall not be liable or responsible.
* Batch No., MRP, Expiry date, Image, description can be changed as per notice, etc.
* Any suppor,supportt please call/Whatsapp us ‪+91 8101099110‬.

Join WhatsApp Channel For Offer & Updates:-  https://whatsapp.com/channel/0029VagZBQk4yltHfZOmXQ0g

Pregabid Cr 165Mg Tab (10 Tab) - Your Trusted Solution by INTAS PHARMACEUTICALS LTD.

Looking for a reliable solution that aligns with your health and wellness needs? Pregabid Cr 165Mg Tab, brought to you by the trusted brand INTAS PHARMACEUTICALS LTD., is here to support your journey to better health. Designed with precision and backed by quality, this product is a go-to choice for those who prioritize effective care.

Why Choose Pregabid Cr 165Mg Tab?

  • Trusted Brand: Manufactured by INTAS PHARMACEUTICALS LTD., a name synonymous with quality and safety in the pharmaceutical industry.
  • Controlled Release Formula: The 165mg controlled-release formulation ensures consistent and prolonged efficacy, reducing the need for frequent dosing.
  • Convenient Packaging: Each pack contains 10 easy-to-swallow tablets, ensuring you have a sufficient supply for your prescribed duration.
  • Quality Assurance: Carefully formulated and tested to meet stringent safety and efficacy standards.

Important Information

Before purchasing, please note the following:

  •